Akari Therapeutics Aktie Analyse
08.02.18 | Akari Therapeutics Neutral | B. Riley FBR, Inc. | |
31.05.17 | Akari Therapeutics Neutral | Chardan Capital Markets |
08.02.18 | Akari Therapeutics Neutral | B. Riley FBR, Inc. | |
31.05.17 | Akari Therapeutics Neutral | Chardan Capital Markets |